(VIANEWS) - Regeneron Pharmaceuticals (REGN), Boston Scientific (BSX), Armada Hoffler Properties (AHH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Regeneron Pharmaceuticals (REGN)
18.3% sales growth and 51.09% return on equity
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide.
Regeneron Pharmaceuticals's sales growth this year is anticipated to be 56.3% and a negative 10.8% for next year.
Year-on-year quarterly revenue growth grew by 50.5%, now sitting on 13.36B for the twelve trailing months.
Volume
Today's last reported volume for Regeneron Pharmaceuticals is 1087480 which is 42.53% above its average volume of 762964.
Regeneron Pharmaceuticals's sales growth for the next quarter is 18.3%. The company's growth estimates for the current quarter and the next is 7.7% and 8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.09%.
Volatility
Regeneron Pharmaceuticals's last day, last week, and last month's current intraday variation average was 3.27%, 0.93%, and 1.04%, respectively.
Regeneron Pharmaceuticals's highest amplitude of average volatility was 4.33% (day), 2.23% (last week), and 2.53% (last month), respectively.
Regeneron Pharmaceuticals's Stock Yearly Top and Bottom Value
Regeneron Pharmaceuticals's stock is valued at $638.41 at 19:22 EST, under its 52-week high of $686.62 and way higher than its 52-week low of $441.00.
Regeneron Pharmaceuticals's Moving Average
Regeneron Pharmaceuticals's worth is above its 50-day moving average of $610.79 and way higher than its 200-day moving average of $567.66.Previous days news about Regeneron Pharmaceuticals(REGN)
- What are whales doing with regeneron pharmaceuticals. According to Benzinga on Friday, 11 February, "Someone with a lot of money to spend has taken a bearish stance on Regeneron Pharmaceuticals REGN.", "Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $340.0 to $720.0 for Regeneron Pharmaceuticals over the last 3 months."
2. Boston Scientific (BSX)
17.5% sales growth and 3.69% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Boston Scientific's sales growth this year is anticipated to be 21.2% and 7.9% for next year.
Year-on-year quarterly revenue growth grew by 53.6%, now sitting on 11.2B for the twelve trailing months.
Volume
Today's last reported volume for Boston Scientific is 6616110 which is 28.09% below its average volume of 9201700.
Boston Scientific's sales growth is a negative 0% for the current quarter and 17.5% for the next. The company's growth estimates for the ongoing quarter and the next is 8.1% and 91.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.69%.
Volatility
Boston Scientific's last day, last week, and last month's current intraday variation average was 1.48%, 1.67%, and 1.31%, respectively.
Boston Scientific's highest amplitude of average volatility was 2.56% (day), 2.35% (last week), and 2.78% (last month), respectively.
Boston Scientific's Stock Yearly Top and Bottom Value
Boston Scientific's stock is valued at $43.11 at 19:22 EST, under its 52-week high of $46.29 and way above its 52-week low of $32.99.
Boston Scientific's Moving Average
Boston Scientific's value is below its 50-day moving average of $43.43 and under its 200-day moving average of $43.52.3. Armada Hoffler Properties (AHH)
8.3% sales growth and 3.55% return on equity
Armada Hoffler Properties, Inc. (NYSE: AHH) is a vertically-integrated, self-managed real estate investment trust ("REIT") with four decades of experience developing, building, acquiring, and managing high-quality, institutional-grade office, retail, and multifamily properties located primarily in the Mid-Atlantic and Southeastern United States.
Armada Hoffler Properties's sales growth this year is anticipated to be 14.8% and 5.7% for next year.
Year-on-year quarterly revenue growth declined by 31.7%, now sitting on 312.66M for the twelve trailing months.
Volume
Today's last reported volume for Armada Hoffler Properties is 149199 which is 67.49% below its average volume of 459054.
Armada Hoffler Properties's sales growth for the next quarter is 8.3%. The company's growth estimates for the current quarter and the next is 300% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.55%.
Volatility
Armada Hoffler Properties's last day, last week, and last month's current intraday variation average was 0.36%, 1.63%, and 1.42%, respectively.
Armada Hoffler Properties's highest amplitude of average volatility was 1.59% (day), 3.13% (last week), and 2.75% (last month), respectively.
Armada Hoffler Properties's Stock Yearly Top and Bottom Value
Armada Hoffler Properties's stock is valued at $13.64 at 19:22 EST, way below its 52-week high of $15.80 and way above its 52-week low of $11.22.
Armada Hoffler Properties's Moving Average
Armada Hoffler Properties's value is under its 50-day moving average of $14.52 and below its 200-day moving average of $13.78.4. ServisFirst Bancshares (SFBS)
6% sales growth and 19.86% return on equity
ServisFirst Bancshares, Inc. operates as the bank holding company for ServisFirst Bank that provides various banking services to individual and corporate customers.
ServisFirst Bancshares's sales growth this year is anticipated to be 13.1% and 5.7% for next year.
Year-on-year quarterly revenue growth grew by 21.5%, now sitting on 380.06M for the twelve trailing months.
Volume
Today's last reported volume for ServisFirst Bancshares is 145274 which is 4.24% below its average volume of 151711.
ServisFirst Bancshares's sales growth for the next quarter is 6%. The company's growth estimates for the present quarter and the next is 4.3% and 3.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.86%.
Volatility
ServisFirst Bancshares's last day, last week, and last month's current intraday variation average was 1.13%, 1.10%, and 1.24%, respectively.
ServisFirst Bancshares's highest amplitude of average volatility was 4.01% (day), 4.08% (last week), and 2.76% (last month), respectively.
ServisFirst Bancshares's Stock Yearly Top and Bottom Value
ServisFirst Bancshares's stock is valued at $84.00 at 19:22 EST, under its 52-week high of $89.35 and way above its 52-week low of $40.76.